Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Data on cancer vaccines described by researchers at School of Science
April 8th, 2008
Investigators publish new data in the report 'Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatments.' "The challenges of late-stage development increasingly are becoming clear as the clinical development of therapeutic cancer vaccines continues to progress. Preclinical and clinical research had indicated that cancer vaccines exert optimal benefit in earlier stage disease or in adjuvant/minimal residual disease (MRD) settings," scientists in London, the United Kingdom report. "However, clinical trials in these settings can be prohibitively slow from a development perspective because of the better...
Source: Cancer Weekly (2008-04-08)
|
